Syneos Health announced a strategic partnership with uMotif. The collaboration will help accelerate clinical trials and bring new therapies to patients faster through a more efficient, end-to-end digital platform that includes robust Electronic Clinical Outcome Assessment and Electronic Patient-reported Outcomes capabilities. In addition to uMotif providing eCOA and ePRO services for Syneos Health customers, the companies will develop and deploy an exclusive patient-centric platform to deliver seamless, integrated customer solutions – including patient identification, recruitment, eConsent, eDiary, patient engagement and retention, and payments. Complemented by the Company’s StudyKIK recruitment technology platform, Syneos Health will build a single application to help drive better engagement, compliance and retention with patients, and reduce site burden.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SYNH:
- Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform
- Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
- Syneos Health Leaders Recognized by HBA
- Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
- Syneos Health Up after Takeover for $7.1 Billion